As of 2024-12-13, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is
-0.12 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.23 CAD, the upside of Newscope Capital Corporation is
-153.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.12 CAD
Intrinsic Value
PHRM.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.12 - -0.12 |
-0.12 |
-153.11% |
| P/E |
(0.02) - (0.15) |
(0.02) |
-108.0% |
| DDM - Stable |
(0.28) - 5.85 |
2.79 |
1111.0% |
| DDM - Multi |
(0.21) - 3.60 |
(0.45) |
-296.1% |
PHRM.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
20.36 |
| Beta |
0.79 |
| Outstanding shares (mil) |
88.52 |
| Enterprise Value (mil) |
18.56 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.91% |
| Cost of Debt |
5.00% |
| WACC |
5.30% |